{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:14:37Z","timestamp":1777623277195,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17PRE33660354"],"award-info":[{"award-number":["17PRE33660354"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["416281"],"award-info":[{"award-number":["416281"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["602349"],"award-info":[{"award-number":["602349"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL141170"],"award-info":[{"award-number":["1R01HL141170"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD) is a severe X-linked neuromuscular disorder that affects males. However, 8% of female carriers are symptomatic and underrepresented in research due to the lack of animal models. We generated a symptomatic mouse model of DMD carriers via injection of<jats:italic>mdx<\/jats:italic>(murine DMD) embryonic stem cells (ESCs) into wild-type (WT) blastocysts (<jats:italic>mdx<\/jats:italic>\/WT chimera).<jats:italic>mdx<\/jats:italic>\/WT chimeras developed cardiomyopathic features and dystrophic skeletal muscle phenotypes including elevated mononuclear invasion, central nucleation, fibrosis and declined forelimb grip strength. The disease was accompanied by connexin-43 (Cx43) aberrantly enhanced in both cardiac and skeletal muscles and remodeled in the heart. Genetic reduction of Cx43-copy number in<jats:italic>mdx<\/jats:italic>\/WT-Cx43(+\/\u2212) chimeras protected them from both cardiac and skeletal muscle fiber damage. In dystrophic skeletal muscle, Cx43 expression was not seen in the fibers but in adjacent F4\/80+ mononuclear cells. Ethidium Bromide uptake in purified F4\/80+\/CD11b+<jats:italic>mdx<\/jats:italic>macrophages revealed functional activity of Cx43, which was inhibited by administration of Gap19 peptide mimetic, a Cx43 hemichannel-specific inhibitor. Thus, we suggest that Cx43 reduction in symptomatic DMD carrier mice leads to prevention of Cx43 remodeling in the heart and prevention of aberrant Cx43 hemichannel activity in the skeletal muscle macrophages neighboring Cx43 non-expressing fibers.<\/jats:p>","DOI":"10.1038\/s41598-020-62844-9","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T10:04:00Z","timestamp":1585562640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Connexin-43 reduction prevents muscle defects in a mouse model of manifesting Duchenne muscular dystrophy female carriers"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6140-1604","authenticated-orcid":false,"given":"Julie","family":"Nouet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Himelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Lahey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Fraidenraich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"62844_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.RES.0000126574.61061.25","volume":"94","author":"KA Lapidos","year":"2004","unstructured":"Lapidos, K. A., Kakkar, R. & McNally, E. M. The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma. Circ. Res. 94, 1023\u20131031 (2004).","journal-title":"Circ. Res."},{"key":"62844_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1399-0004.1974.tb01694.x","volume":"5","author":"H Moser","year":"1974","unstructured":"Moser, H. & Emery, A. E. H. The manifesting carrier in Duchenne muscular dystrophy. Clin. Genet. 5, 271\u201384 (1974).","journal-title":"Clin. Genet."},{"key":"62844_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.nmd.2010.05.010","volume":"20","author":"P Soltanzadeh","year":"2010","unstructured":"Soltanzadeh, P. et al. Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul. Disord. 20, 499\u2013504 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"62844_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3988\/jcn.2015.11.3.248","volume":"11","author":"SH Lee","year":"2015","unstructured":"Lee, S. H., Lee, J. H., Lee, K. A. & Choi, Y. C. Clinical and genetic characterization of female dystrophinopathy. J. Clin. Neurol. 11, 248\u201351 (2015).","journal-title":"J. Clin. Neurol."},{"key":"62844_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3349\/ymj.2011.52.1.192","volume":"52","author":"TJ Song","year":"2011","unstructured":"Song, T. J., Lee, K. A., Kang, S. W., Cho, H. & Choi, Y. C. Three cases of manifesting female carriers in patients with duchenne muscular dystrophy. Yonsei Med. J. 52, 192\u20135 (2011).","journal-title":"Yonsei Med. J."},{"key":"62844_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","volume":"275","author":"L Politano","year":"1996","unstructured":"Politano, L. et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. J. Am. Med. Assoc. 275, 1335\u20138 (1996).","journal-title":"J. Am. Med. Assoc."},{"key":"62844_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-82","volume":"7","author":"J Juan-Mateu","year":"2012","unstructured":"Juan-Mateu, J. et al. Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy. Orphanet J. Rare Dis. 7, 82 (2012).","journal-title":"Orphanet J. Rare Dis."},{"key":"62844_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pediatrneurol.2015.11.004","volume":"55","author":"R Papa","year":"2016","unstructured":"Papa, R. et al. Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne\/Becker Muscular Dystrophy. Pediatr. Neurol. 55, 58\u201363 (2016).","journal-title":"Pediatr. Neurol."},{"key":"62844_CR9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ejhg.2012.269","volume":"21","author":"S Mercier","year":"2013","unstructured":"Mercier, S. et al. Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age. Eur. J. Hum. Genet. 21, 855\u201363 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"62844_CR10","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/S0140-6736(98)10028-4","volume":"353","author":"EM Hoogerwaard","year":"1999","unstructured":"Hoogerwaard, E. M. et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: A cohort study. Lancet. 353, 2116\u20139 (1999).","journal-title":"Lancet."},{"key":"62844_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/mus.880121013","volume":"12","author":"SC Watkins","year":"1989","unstructured":"Watkins, S. C., Hoffman, P., Slayter, H. S. & Kunkel, L. M. Dystrophin distribution in heterozygote mdx mice. Muscle & Nerve. 12, 861\u20138 (1989).","journal-title":"Muscle & Nerve."},{"key":"62844_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.107.162982","volume":"102","author":"B Bostick","year":"2008","unstructured":"Bostick, B., Yue, Y., Long, C. & Duan, D. Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin\/utrophin expression. Circ. Res. 102, 121\u201330 (2008).","journal-title":"Circ. Res."},{"key":"62844_CR13","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","volume":"81","author":"G Bulfield","year":"1984","unstructured":"Bulfield, G., Siller, W. G., Wight, P. A. & Moore, K. J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. 81, 1189\u20131192 (1984).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"62844_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/stem.2518","volume":"35","author":"JP Gonzalez","year":"2017","unstructured":"Gonzalez, J. P. et al. Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras. Stem Cells. 35, 597\u2013610 (2017).","journal-title":"Stem Cells."},{"key":"62844_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-13-73","volume":"13","author":"S Brioschi","year":"2012","unstructured":"Brioschi, S. et al. Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype. BMC Med. Genet. 13, 73 (2012).","journal-title":"BMC Med. Genet."},{"key":"62844_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep13490","volume":"27","author":"J Patrick Gonzalez","year":"2015","unstructured":"Patrick Gonzalez, J., Ramachandran, J., Xie, L. H., Contreras, J. E. & Fraidenraich, D. Selective Connexin43 Inhibition Prevents Isoproterenol-Induced Arrhythmias and Lethality in Muscular Dystrophy Mice. Sci. Rep. 27, 13490 (2015).","journal-title":"Sci. Rep."},{"key":"62844_CR17","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/labinvest.3700324","volume":"85","author":"LC Lin","year":"2005","unstructured":"Lin, L. C. et al. Downregulated myocardial connexin 43 and suppressed contractility in rabbits subjected to a cholesterol-enriched diet. Lab. Investig. 85, 1224\u201337 (2005).","journal-title":"Lab. Investig."},{"key":"62844_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pharmthera.2015.06.005","volume":"153","author":"R Schulz","year":"2015","unstructured":"Schulz, R. et al. Connexin 43 is an emerging therapeutic target in ischemia\/reperfusion injury, cardioprotection and neuroprotection. Pharmacol. Ther. 153, 106 (2015).","journal-title":"Pharmacol. Ther."},{"key":"62844_CR19","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1242\/jcs.200667","volume":"130","author":"TM Ribeiro-Rodrigues","year":"2017","unstructured":"Ribeiro-Rodrigues, T. M., Martins-Marques, T., Morel, S., Kwak, B. R. & Gir\u00e3o, H. Role of connexin 43 in different forms of intercellular communication \u2013 gap junctions, extracellular vesicles and tunnelling nanotubes. J. Cell Sci. 130, 3619\u20133630 (2017).","journal-title":"J. Cell Sci."},{"key":"62844_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nrd.2018.138","volume":"17","author":"DW Laird","year":"2018","unstructured":"Laird, D. W. & Lampe, P. D. Therapeutic strategies targeting connexins. Nat. Rev. Drug Discov. 17, 905\u2013921 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62844_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.molmed.2018.10.005","volume":"24","author":"T Delvaeye","year":"2018","unstructured":"Delvaeye, T., Vandenabeele, P., Bultynck, G., Leybaert, L. & Krysko, D. V. Therapeutic Targeting of Connexin Channels: New Views and Challenges. Trends Mol. Med. 24, 1036\u20131053 (2018).","journal-title":"Trends Mol. Med."},{"key":"62844_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2015.10.030","volume":"768","author":"P Michela","year":"2015","unstructured":"Michela, P., Velia, V., Aldo, P. & Ada, P. Role of connexin 43 in cardiovascular diseases. Eur. J. Pharmacol. 768, 71\u20136 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"62844_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.yjmcc.2012.07.008","volume":"53","author":"G Hawat","year":"2012","unstructured":"Hawat, G., H\u00e9lie, P. & Baroudi, G. Single intravenous low-dose injections of connexin 43 mimetic peptides protect ischemic heart in vivo against myocardial infarction. J. Mol. Cell. Cardiol. 53, 559\u201366 (2012).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"62844_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.nmd.2018.01.012","volume":"28","author":"JP Gonzalez","year":"2018","unstructured":"Gonzalez, J. P. et al. Normalization of connexin 43 protein levels prevents cellular and functional signs of dystrophic cardiomyopathy in mice. Neuromuscul. Disord. 28, 361\u2013372 (2018).","journal-title":"Neuromuscul. Disord."},{"key":"62844_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/cvr\/cvn133","volume":"80","author":"NJ Severs","year":"2008","unstructured":"Severs, N. J., Bruce, A. F., Dupont, E. & Rothery, S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc. Res. 80, 9\u201319 (2008).","journal-title":"Cardiovasc. Res."},{"key":"62844_CR26","first-page":"404","volume":"17","author":"AG Kleber","year":"2014","unstructured":"Kleber, A. G. & Saffitz, J. E. Role of the intercalated disc in cardiac propagation and arrhythmogenesis. Front. Physiol. 17, 404 (2014).","journal-title":"Front. Physiol."},{"key":"62844_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00395-012-0309-x","volume":"108","author":"N Wang","year":"2013","unstructured":"Wang, N. et al. Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia\/reperfusion injury. Basic Res. Cardiol. 108, 309 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"62844_CR28","doi-asserted-by":"crossref","unstructured":"Lillo, M. A., Himelman, E., Xie, L.-H., Fraidenraich, D. & Contreras, J. E. S-Nitrosylation of Cx43 Hemichannels Promotes Cardiac Arrhythmias in a Duchene Muscular Dystrophy Mouse Model. Biophys. J. 4 (2019).","DOI":"10.1172\/jci.insight.130091"},{"key":"62844_CR29","doi-asserted-by":"crossref","unstructured":"Himelman, E. et al. Prevention of Connexin43 remodeling protects against duchenne muscular dystrophy cardiomyopathy. J. Clin. Invest. (2020).","DOI":"10.1172\/JCI128190"},{"key":"62844_CR30","doi-asserted-by":"crossref","unstructured":"Ishido, M. & Kasuga, N. Characteristics of the Localization of Connexin 43 in Satellite Cells during Skeletal Muscle Regeneration In Vivo. Acta Histochem. Cytochem. 48, 53\u201360 (2015).","DOI":"10.1267\/ahc.14056"},{"key":"62844_CR31","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.1073\/pnas.1312331110","volume":"110","author":"LA Cea","year":"2013","unstructured":"Cea, L. A. et al. De novo expression of connexin hemichannels in denervated fast skeletal muscles leads to atrophy. Proc. Natl. Acad. Sci. 110, 16229\u201334 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"62844_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2015.12.001","volume":"104","author":"Y Kim","year":"2016","unstructured":"Kim, Y. et al. Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway. Adv. Protein Chem. Struct. Biol. 104, 1\u201337 (2016).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"62844_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-55330-6_12","volume":"982","author":"K Boengler","year":"2017","unstructured":"Boengler, K. & Schulz, R. Connexin 43 and mitochondria in cardiovascular health and disease. Adv. Exp. Med. Biol. 982, 227\u2013246 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"62844_CR34","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00018-016-2132-2","volume":"73","author":"LA Cea","year":"2016","unstructured":"Cea, L. A. et al. Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis. Cell. Mol. Life Sci. 73, 2583\u201399 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"62844_CR35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/352536a0","volume":"352","author":"HH Stedman","year":"1991","unstructured":"Stedman, H. H. et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 352, 536\u20139 (1991).","journal-title":"Nature."},{"key":"62844_CR36","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.chest.2018.08.1028","volume":"154","author":"BJ Petrof","year":"2018","unstructured":"Petrof, B. J. Diaphragm Weakness in the Critically Ill: Basic Mechanisms Reveal Therapeutic Opportunities. Chest. 154, 1395\u20131403 (2018).","journal-title":"Chest."},{"key":"62844_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18452-1","volume":"8","author":"W Li","year":"2018","unstructured":"Li, W. et al. Connexin 43 Hemichannel as a Novel Mediator of Sterile and Infectious Inflammatory Diseases. Sci. Rep. 8, 166 (2018).","journal-title":"Sci. Rep."},{"key":"62844_CR38","doi-asserted-by":"publisher","first-page":"e42670","DOI":"10.7554\/eLife.42670","volume":"8","author":"M Dosch","year":"2019","unstructured":"Dosch, M. et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. eLife. 8, e42670 (2019).","journal-title":"eLife."},{"key":"62844_CR39","doi-asserted-by":"crossref","unstructured":"Dort, J., Fabre, P., Molina, T. & Dumont, N. A. Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases. Stem Cells Int. 4761427 (2019).","DOI":"10.1155\/2019\/4761427"},{"key":"62844_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.stem.2019.01.002","volume":"24","author":"YX Wang","year":"2019","unstructured":"Wang, Y. X. et al. EGFR-Aurka Signaling Rescues Polarity and Regeneration Defects in Dystrophin-Deficient Muscle Stem Cells by Increasing Asymmetric Article EGFR-Aurka Signaling Rescues Polarity and Regeneration Defects in Dystrophin-Deficient Muscle Stem Cells by Increasin. Cell Stem Cell. 24, 419\u2013432 (2019).","journal-title":"Cell Stem Cell."},{"key":"62844_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10974-019-09511-3","volume":"40","author":"B Chen","year":"2019","unstructured":"Chen, B. & Shan, T. The role of satellite and other functional cell types in muscle repair and regeneration. J. Muscle Res. Cell Motility. 40, 1\u20138 (2019).","journal-title":"J. Muscle Res. Cell Motility."},{"key":"62844_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/(SICI)1520-6408(1997)20:2<133::AID-DVG6>3.0.CO;2-8","volume":"20","author":"A Proulx","year":"1997","unstructured":"Proulx, A., Merrifield, P. A. & Naus, C. C. G. Blocking gap junctional intercellular communication in myoblasts inhibits myogenin and MRF4 expression. Dev. Genet. 20, 133\u201344 (1997).","journal-title":"Dev. Genet."},{"key":"62844_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00924-7","volume":"8","author":"JS Novak","year":"2017","unstructured":"Novak, J. S. et al. Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle. Nat. Commun. 8, 941 (2017).","journal-title":"Nat. Commun."},{"key":"62844_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/cac.10.4-6.451.456","volume":"10","author":"R Araya","year":"2003","unstructured":"Araya, R., Eckardt, D., Riquelme, M., Willecke, K. & S\u00e1ez, J. Presence and Importance of Connexin43 During Myogenesis. Cell Commun. Adhes. 10, 451\u20136 (2003).","journal-title":"Cell Commun. Adhes."},{"key":"62844_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcdb.2015.12.001","volume":"50","author":"PA Merrifield","year":"2016","unstructured":"Merrifield, P. A. & Laird, D. W. Connexins in skeletal muscle development and disease. Semin. Cell Dev. Biol. 50, 57\u201373 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"62844_CR46","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.yexcr.2007.01.012","volume":"313","author":"A Gorbe","year":"2007","unstructured":"Gorbe, A., Krenacs, T., Cook, J. E. & Becker, D. L. Myoblast proliferation and syncytial fusion both depend on connexin43 function in transfected skeletal muscle primary cultures. Exp. Cell Res. 313, 1135\u201348 (2007).","journal-title":"Exp. Cell Res."},{"key":"62844_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2015.00267","volume":"9","author":"MA Retamal","year":"2015","unstructured":"Retamal, M. A. et al. Diseases associated with leaky hemichannels. Front. Cell. Neurosci. 9, 1\u201310 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"62844_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-016-0120-x","volume":"18","author":"AB Belousov","year":"2017","unstructured":"Belousov, A. B., Fontes, J. D., Freitas-Andrade, M. & Naus, C. C. Gap junctions and hemichannels: Communicating cell death in neurodevelopment and disease. BMC Cell Biol. 18, 4 (2017).","journal-title":"BMC Cell Biol."},{"key":"62844_CR49","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.bbadis.2016.07.003","volume":"1862","author":"LA Cea","year":"2016","unstructured":"Cea, L. A. et al. Dexamethasone-induced muscular atrophy is mediated by functional expression of connexin-based hemichannels. Biochim. Biophys. Acta - Mol. Basis Dis. 1862, 1891\u20139 (2016).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"62844_CR50","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.tcb.2009.07.005","volume":"19","author":"L Helming","year":"2009","unstructured":"Helming, L. & Gordon, S. Molecular mediators of macrophage fusion. Trends Cell Biol. 19, 514\u201322 (2009).","journal-title":"Trends Cell Biol."},{"key":"62844_CR51","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/stem.1288","volume":"31","author":"M Saclier","year":"2013","unstructured":"Saclier, M. et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells. 31, 384\u201396 (2013).","journal-title":"Stem Cells."},{"key":"62844_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnmol.2019.00023","volume":"12","author":"LY Xing","year":"2019","unstructured":"Xing, L. Y., Yang, T., Cui, S. S. & Chen, G. Connexin hemichannels in astrocytes: Role in CNS disorders. Front. Mol. Neurosci. 12, 23 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"62844_CR53","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1073\/pnas.92.15.7011","volume":"92","author":"PI Jara","year":"1995","unstructured":"Jara, P. I., Boric, M. P. & S\u00e1ez, J. C. Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion. Proc. Natl. Acad. Sci. USA 92, 7011\u20135 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62844_CR54","first-page":"12","volume":"15","author":"RJ Anand","year":"2008","unstructured":"Anand, R. J. et al. A role for connexin43 in macrophage phagocytosis and host survival after bacterial peritoneal infection. J. Immunol. 15, 12 (2008).","journal-title":"J. Immunol."},{"key":"62844_CR55","first-page":"8534","volume":"181","author":"DG Allen","year":"2015","unstructured":"Allen, D. G., Whitehead, N. P. & Froehner, S. C. Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca 2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. Physiol. Rev. 181, 8534\u20138543 (2015).","journal-title":"Physiol. Rev."},{"key":"62844_CR56","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/14728222.2018.1482279","volume":"22","author":"JS Novak","year":"2018","unstructured":"Novak, J. S., Jaiswal, J. K. & Partridge, T. A. The macrophage as a Trojan horse for antisense oligonucleotide delivery. Expert Opin. Ther. Targets. 22, 463\u2013466 (2018).","journal-title":"Expert Opin. Ther. Targets."},{"key":"62844_CR57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ymthe.2006.01.007","volume":"14","author":"Y Yue","year":"2006","unstructured":"Yue, Y., Liu, M. & Duan, D. C-Terminal-Truncated Microdystrophin Recruits Dystrobrevin and Syntrophin to the Dystrophin-Associated Glycoprotein Complex and Reduces Muscular Dystrophy in Symptomatic Utrophin\/Dystrophin Double-Knockout Mice. Mol. Ther. 14, 79\u201387 (2006).","journal-title":"Mol. Ther."},{"key":"62844_CR58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.21873","volume":"43","author":"JH Shin","year":"2011","unstructured":"Shin, J. H., Hakim, C. H., Zhang, K. & Duan, D. Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction. Muscle and Nerve. 43, 283\u20136 (2011).","journal-title":"Muscle and Nerve."},{"key":"62844_CR59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/9780470942390.mo100130","volume":"1","author":"S Gao","year":"2011","unstructured":"Gao, S., Ho, D., Vatner, D. E. & Vatner, S. F. Echocardiography in Mice. Curr. Protoc. Mouse Biol. 1, 71\u201383 (2011).","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"62844_CR60","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson, M. et al. A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes from the Adult Mouse Heart. Circ. Res. 119, 909\u201320 (2016).","journal-title":"Circ. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62844-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62844-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62844-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T08:08:46Z","timestamp":1695974926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62844-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62844"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62844-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"4 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.N., E.H. and K.C.L. have no competing interests D.F. is a member of the Editorial Board of Scientific Reports. Q.Z. and D.F. have the following patent: \u201cCorrective roles of insulin-like growth factor-binding protein-3 in cardiomyopathy\u201d. United States Patent No. 8,802,629, issued on Aug. 12, 2014, assigned to Rutgers, The State University of New Jersey (New Brunswick, New Jersey).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5683"}}